Antares Pharma Forecast and Stock Analysis
Technical ATRS stock analysis for February 14, 2019.
Antares Pharma fell by -1.27% in the last day from $3.15 to $3.11 and has now fallen 4 days in a row. The price has fallen in 5 of the last 10 days , but is still up by 2.98% over the past 2 weeks. Volume has increased in the last day by 50 193 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 362 969 shares bought and sold for approximately $1.13 million.
Close price at the end of the last trading day (Thursday, 14th Feb 2019) of the ATRS stock was $3.11. This is 1.27% less than the trading day before Wednesday, 13th Feb 2019.
During day the stock fluctuated 2.59% from a day low at $3.09 to a day high of $3.17.
30 day high of the ATRS stock price was $3.35 and low was $2.90.
90 day high was $3.70 and low was $2.53.
52 week high for the Antares Pharma - $3.93 and low - $1.99.
Antares Pharma lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.46% during the next 3 months and, with 90% probability hold a price between $2.28 and $3.17 at the end of this period.
There are mixed signals in the stock today. A sales signal was issued from a pivot top point on Monday February 11, 2019, which indicates further falls until a new bottom pivot has been found. Antares Pharma gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's". Antares Pharma holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $3.17. On a fall, the stock will find some support from the long-term average at approximately $3.02. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal.
Relative Strength Index (RSI)
RSI14 is 54 and the stock is currently not being overbought or oversold
Support & Resistance
Antares Pharma finds support from accumulated volume at $3.02.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.08 (2.59%) between high and low. For the last week, the stock has had a daily average volatility of 3.23%.
Our recommended stoploss: $2.99 (-3.92%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from pivot top found 3 days ago.)
Very Low Low Medium High Very High
Antares Pharma holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development.